MapLight Therapeutics MPLT Cash Flow Statement (2024-2026)

NASDAQ MPLT
$7.55 +0.27 (+3.71%)
As of: Nov 10, 2026 · 2:46 PM EST
Reported Financials

MapLight Therapeutics Quarterly Cash Flow Statement

Periods 7 quarters
Latest Jun 2026

MapLight Therapeutics reported cash from operations of -$44.87M and free cash flow of -$44.89M for the quarter ended Jun 2026. This cash flow statement covers 7 quarters of results from Sep 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Sep2024 Dec2024 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income -19.02M-21.23M-29.85M-29.42M-79.55M-60.19M
Depreciation and DepletionDep. & Depletion 0.20M0.19M0.10M0.16M0.16M0.15M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort. 0.20M0.19M0.10M0.16M0.16M0.15M
Share-based CompensationStock Comp. 0.35M0.21M0.15M0.13M35.52M8.63M
Gains from Sales and DivestituresGains Divest -0.01M0.00M
Other non-cash itemsOther Non-Cash 0.21M0.22M0.22M0.23M0.22M
Change in Working Capital
Change in Account PayablesChange Payables -0.16M0.30M0.89M-0.11M-1.13M
Change in Accrued ExpensesChange Accrued Exp. 1.21M2.61M1.12M-1.88M5.84M
Change in Other Operating AssetsOther Assets Change 1.40M3.91M2.33M-2.48M-2.85M
Change in Other Operating LiabilitiesOther Liabilities Change -0.18M-0.20M-0.20M-0.21M-0.23M
Other Working Capital ChangesOther WC Changes -1.57M-4.11M-2.53M2.26M2.62M
Cash from OperationsCash from Ops. -21.49M-31.79M-46.83M-51.18M-44.87M
Investing Activities
Capital ExpendituresCapex 0.11M0.03M0.38M0.02M0.02M
Change in Property, Plant and EquipmentChange in PP&E -0.11M-0.03M-0.38M-0.02M-0.02M
Purchase of InvestmentsInvestments Purchased 142.06M266.18M
Sale and Maturity of InvestmentsInvestments Sold 32.50M6.50M24.00M67.03M80.50M
Cash from Investing ActivitiesCash from Investing 32.39M-135.59M-242.55M67.01M60.70M
Financing Activities
Change in Capital Stock
Common Stock IssuedStock Issued 0.02M0.10M0.17M
Net Shares Issued and RepurchasedNet Shares Issued 0.02M0.10M0.17M
Net Equity Issued and RepurchasedNet Equity Issued 0.02M0.10M0.17M
Other financing activities (as filed) -0.02M-0.92M-3.89M-7.50M
Cash from Financing ActivitiesCash from Financing 0.01M198.06M271.97M-6.85M0.09M
Additional items
Change in Cash 10.91M30.68M-17.42M8.98M15.93M
Ending Cash Balance 27.55M38.46M33.67M64.35M46.94M71.84M
Free Cash FlowFCF -21.59M-31.82M-47.21M-51.20M-44.89M
Net Cash FlowNCF 10.91M30.68M-17.42M8.98M15.93M

MapLight Therapeutics Cash Flow Statement API

Pull MapLight Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=MPLT&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY